Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III randomized double-blind trial of ISA247 vs ciclosporin vs placebo in plaque psoriasis
2006-001352-13Phase 3Completed
- Sponsor
- Aurinia
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of voclosporin in plaque psoriasis (3 arms), sponsored by Aurinia. Primary endpoints: Primary SPGA response vs placebo and Primary non-inferiority vs ciclosporin. Started Jul 2006; status: completed.
02
Drugs
voclosporin
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2006-001352-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001352-13.